About

Alexandre Fontayne, PhD, has worked for Unither Pharmaceuticals as Chief Scientific Officer for biological products since 2021 and is deeply involved in the development of the Euroject device. He received his PhD in Biological Science at Université Paris Sud (Paris, France) and has 20 years of experience in research and development, including 13 years in the pharmaceutical industry working on drug design and bioproduction of biologics, including ublituximab. Dr Fontayne is co-author of 28 scientific articles and holds 12 patents.

He contributes to the training of students and employees in drug design, chemistry, manufacturing and controls activities and subcontracting.